Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma

We have shown that the proteasome inhibitor bortezomib (formerly known as PS-341) triggers significant antitumor activity in multiple myeloma (MM) in both preclinical models and patients with relapsed refractory disease. Recent studies have shown that unfolded and misfolded ubiquitinated proteins ar...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hideshima, Teru, Bradner, James E., Wong, Jason, Chauhan, Dharminder, Richardson, Paul, Schreiber, Stuart L., Anderson, Kenneth C.
Formato: Artigo
Idioma:Inglês
Publicado em: National Academy of Sciences 2005
Assuntos:
Biological Sciences
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1150844/
https://ncbi.nlm.nih.gov/pubmed/15937109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0503221102
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados